Literature DB >> 16464566

Transcription factors drive B cell development.

James Hagman1, Kara Lukin.   

Abstract

Transcription factors including PU.1, E2A and early B cell factor (EBF) are essential for the earliest stages of B lymphocyte development. Recent advances suggest that, although PU.1 initiates events leading to B lymphopoiesis, it might be dispensable at later stages of development. E2A proteins are also crucial for B cell lineage determination, as shown by the pluripotency of E2A-deficient progenitors. Both PU.1 and E2A are required for expression of EBF. EBF activates the early program of genes unique to B cells, including the lineage commitment factor Pax5. EBF also facilitates the function of Pax5 by mediating epigenetic changes necessary for the function of Pax5 at gene targets. Together, these proteins function in a hierarchy of factors that orchestrates B cell development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464566     DOI: 10.1016/j.coi.2006.01.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  40 in total

1.  Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program.

Authors:  Michael R Green; Stefano Monti; Riccardo Dalla-Favera; Laura Pasqualucci; Nicole C Walsh; Marc Schmidt-Supprian; Jeffery L Kutok; Scott J Rodig; Donna S Neuberg; Klaus Rajewsky; Todd R Golub; Frederick W Alt; Margaret A Shipp; John P Manis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

2.  Use of biotinylated plasmid DNA as a surrogate for HSV DNA to identify proteins that repress or activate viral gene expression.

Authors:  Stephen Mallon; Bassam T Wakim; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-05       Impact factor: 11.205

3.  The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1.

Authors:  Ryan M Raver; Amanda R Panfil; Stacy R Hagemeier; Shannon C Kenney
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

4.  Id1 has a physiological role in regulating early B lymphopoiesis.

Authors:  Shawn W Cochrane; Ying Zhao; S Scott Perry; Thomas Urbaniak; Xiao-Hong Sun
Journal:  Cell Mol Immunol       Date:  2010-12-06       Impact factor: 11.530

5.  B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.

Authors:  Diana Cozma; Duonan Yu; Suchita Hodawadekar; Anna Azvolinsky; Shannon Grande; John W Tobias; Michele H Metzgar; Jennifer Paterson; Jan Erikson; Teresa Marafioti; John G Monroe; Michael L Atchison; Andrei Thomas-Tikhonenko
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

6.  Reciprocal patterns of methylation of H3K36 and H3K27 on proximal vs. distal IgVH genes are modulated by IL-7 and Pax5.

Authors:  Cheng-Ran Xu; Lana Schaffer; Steven R Head; Ann J Feeney
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-17       Impact factor: 11.205

7.  Distinct Genetic Networks Orchestrate the Emergence of Specific Waves of Fetal and Adult B-1 and B-2 Development.

Authors:  Encarnacion Montecino-Rodriguez; Michael Fice; David Casero; Beata Berent-Maoz; Chad L Barber; Kenneth Dorshkind
Journal:  Immunity       Date:  2016-08-23       Impact factor: 31.745

8.  Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment.

Authors:  Xiaomin Zheng; Claudia Oancea; Reinhard Henschler; Malcolm A S Moore; Martin Ruthardt
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

Review 9.  The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis.

Authors:  Frank J T Staal; Jyoti M Sen
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

10.  Highly cooperative recruitment of Ets-1 and release of autoinhibition by Pax5.

Authors:  Daniel Fitzsimmons; Kara Lukin; Ryan Lutz; Colin W Garvie; Cynthia Wolberger; James Hagman
Journal:  J Mol Biol       Date:  2009-07-17       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.